E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma

Virchows Archiv

Volumn 460, Issue 5, 2012, Pages 439-446

  Palaiologou, Marina ^a   Koskinas, John ^b   Karanikolas, Menelaos ^c   Fatourou, Evangelia ^d   Tiniakos, Dina G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; E2F 1; Hepatocellular carcinoma; Phospho(Ser795) pRb; pRb

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL; VIRUS HEPATITIS;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; TUMOR MARKERS, BIOLOGICAL;

EID: 84863722030     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1220-4     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108 (Pubitemid 40372904)
2. Ferlay J, Shin HR, Bray F, Forman D,Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917. doi:10.1002/ijc.25516
3. Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ (2008) Viral hepatocarcinogenesis: from infection to cancer. Liver Int 28:175-188. doi:10.1111/j.1478-3231.2007.01652.x (Pubitemid 351201032)
4. Wong CM, Ng IOL (2008) Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28:160-174. doi:10.1111/j.1478-3231.2007.01637.x (Pubitemid 351201031)
5. Hallstrom TC, Nevins JR (2009) Balancing the decision of cell proliferation and cell fate. Cell Cycle 15:532-535. doi:10.4161/ cc.8.4.7609
6. Tsantoulis PK, Gorgoulis VG (2005) Involvement of E2F transcription factor family in cancer. Eur J Cancer 41:2403-2414. doi:10.1016/j.ejca.2005.08. 005 (Pubitemid 41540618)
7. Polager S, Ginsberg D (2008) E2F-at the crossroads of life and death. Trends Cell Biol 18:528-536. doi:10.1016/j.tcb.2008.08.003
8. Gorgoulis VG, Zacharatos P, Mariatos M et al (2002) Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinoma. J Pathol 198:142-156. doi:10.1002/path.1121 (Pubitemid 35243872)
9. Zacharatos P, Kotsinas A, Evangelou K et al (2004) Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol 203:744-753. doi:10.1002/path.1582 (Pubitemid 38961560)
10. Conner AE, Lemmer RE, Omori M et al (2000) Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19:5054-5562
11. Ladu S, Cabisi DF, Conner EA, Farina M, Factor VM, Thorgeirsson SS (2008) E2F1 inhibits c-Myc driven apoptosis via PIK3CA/Akt/ mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 135:1322-1332. doi:10.1053/j.gastro.2008.07.012
12. Nakajima T, Yasui K, Zen K et al (2008) Activation of B-Myb by E2F1 in hepatocellular carcinoma. Hepatol Res 38:886-895. doi:10.1111/j.1872-034X.2008. 00324.x
13. Huynh H, Do PT, Nguyen TH et al (2004) (2004) Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma
14. Anthony PP, Ishak K, Nayak NC (1978) The morphology of cirrhosis. J Clin Pathol 31:395-414
15. Bosman TF, Carneiro F, Hruban HR, Theise DN (2010) WHO classification of tumours of the digestive system. IARC Press, Lyon, pp 205-216
16. Ishak K, Baptista A, Bianchi L, Callea F (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
17. Ishak KG, Goodman ZD, Stocker JT (2001) Tumors of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, 3rd series, Fascicle AFIP, Washington, DC, pp 219-220
18. Koskinas J, Petraki K, Kavantzas N et al (2005) Hepatic expression of the proliferative marker Ki67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat 12:635-641. doi:10.1111/ j.1365-2893.2005.00635.x (Pubitemid 41532495)
19. Roesch A, Becker B, Meyer S et al (2005) Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma. Mod Pathol 18:565-572. doi:10.1038/ modpathol.3800324 (Pubitemid 40478121)
20. Yamazaki M, Hasegawa M, Ohaka I et al (2005) Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. J Clin Pathol 58:904-910 (Pubitemid 41265272)
21. Yamazaki K, Yajima T, Nagao T (2003) Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. Pathol Res Pract 199:23-28 (Pubitemid 36322359)
22. Suh DS, Yoon MS, Choi KU, Kim JY (2008) Significance of E2F-1 overexpression in epithelial ovarian cancer. Int J Gynecol Cancer 18:492-498 (Pubitemid 351668312)
23. Evangelou K, Kotsinas A, Mariolis-Sapsakos T et al (2008) E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol 65:601-605 (Pubitemid 351678211)
24. Liontos M, Niforou K, Velimezi G et al (2009) Modulation of the E2F1-driven cancer cell fate by DNA damage response machinery and potential E2F1 targets in osteosarcoma. Am J Pathol 175:376-391. doi:10.2353/ajpath.2009. 081160
25. Grassi A, Susca M, Ferri S et al (2004) Detection of the M30 neoepitope as a new tool to quantify liver apoptosis. Am J Clin Pathol 121:211-219. doi:10.1309/UK621LFJ4FX07KDE
26. Iwamoto M, Benerjee D, Menon LG et al (2004) Overexpression of the E2F-1 in lung and liver metastasis of human colon cancer is associated with gene amplification. Cancer Biol Ther 3:395-399. doi:10.4161/cbt.3.4.733 (Pubitemid 41350870)
27. Azechi H, Nishida N, Fukuda Y et al (2001) Disruption of the p16/ cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 60:346-354. doi:10.1159/ 000058531 (Pubitemid 32623450)
28. Liu K, Lei XZ, Zhao LS et al (2005) Tissue microarray for highthroughput analysis of gene expression profiles in hepatocellular carcinoma. World J Gastroenterol 11:1369-1372 (Pubitemid 40425923)
29. Tan L, Fu X-Y, Liu S-Q et al (2005) Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma. Liver Int 25:667-676. doi:10.1111/j.1478-3231.2005.01003.x (Pubitemid 40861916)
30. Wang WH, Hullinger RL, Andrisani OM (2008) Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem 283:25455-2567. doi:10.1074/jbc.M801934200
31. Machida K, Liu JC,McNamara G et al (2009) Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol 83:12590-12600. doi:10.1128/JVI.02643-08
32. de la Luna S, Burden M, Lee C et al (1996) Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J Cell Sci 109:1717-1726
33. RohV, LaemmleA,Von HolzenU et al (2008)Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther 15:636-644. doi:10.1038/ cgt.2008.34